KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Halozyme Therapeutics (HALO) Total Current Liabilities (2016 - 2025)

Halozyme Therapeutics (HALO) has disclosed Total Current Liabilities for 16 consecutive years, with $177.1 million as the latest value for Q4 2025.

  • Quarterly Total Current Liabilities rose 27.31% to $177.1 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $177.1 million through Dec 2025, up 27.31% year-over-year, with the annual reading at $177.1 million for FY2025, 27.31% up from the prior year.
  • Total Current Liabilities for Q4 2025 was $177.1 million at Halozyme Therapeutics, down from $837.2 million in the prior quarter.
  • The five-year high for Total Current Liabilities was $837.2 million in Q3 2025, with the low at $91.9 million in Q1 2023.
  • Average Total Current Liabilities over 5 years is $162.6 million, with a median of $116.8 million recorded in 2021.
  • The sharpest move saw Total Current Liabilities tumbled 72.2% in 2021, then skyrocketed 669.4% in 2025.
  • Over 5 years, Total Current Liabilities stood at $117.1 million in 2021, then grew by 11.65% to $130.8 million in 2022, then dropped by 13.99% to $112.5 million in 2023, then rose by 23.65% to $139.1 million in 2024, then increased by 27.31% to $177.1 million in 2025.
  • According to Business Quant data, Total Current Liabilities over the past three periods came in at $177.1 million, $837.2 million, and $134.3 million for Q4 2025, Q3 2025, and Q2 2025 respectively.